Status:
UNKNOWN
Endoscopic Ultrasound Guided Gastric Botulinum Toxin Injections Versus Glucagon Like Peptide 1 Receptor Agonist in Weight Loss
Lead Sponsor:
Mansoura University
Conditions:
Obesity
Eligibility:
All Genders
20-60 years
Phase:
NA
Brief Summary
Background: Obesity is an important public health concern. Surgery is effective but invasive and expensive, and some obese persons are not good surgical candidates. Aim: Compare safety, feasibility ...
Detailed Description
Introduction Obesity is an important public health concern. Although most pharmacologic therapies have targeted the central nervous system, surgical treatments induce satiation by decreasing the size...
Eligibility Criteria
Inclusion
- Sex: both Age: from 20 to 60 years Body Mass Index \> 30
Exclusion
- Age: below 20 or above 60 years old. Patient with known gastroparesis Peptic ulcer disease or active upper gastrointestinal ulceration Prior gastric or small bowel surgery American Society of Anesthesiologists (ASA) class 3 or higher Patients with more than mild , infrequent symptoms of upper abdominal pain or nausea Pregnant or lactating female Contraindications of sedation (Uncontrolled Diabetes Mellitus, Uncontrolled Thyroid Disorders, Pregnancy, Respiratory Embarrassment, Reactional Drugs like Antidepressants and Anti-anxiety Agents).
Key Trial Info
Start Date :
January 27 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 27 2023
Estimated Enrollment :
38 Patients enrolled
Trial Details
Trial ID
NCT05268627
Start Date
January 27 2022
End Date
January 27 2023
Last Update
March 7 2022
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Specialized Medical Hospital,Mansoura University
Al Mansurah, Dakhlia, Egypt, 35516
2
MansouraU
Al Mansurah, Egypt